The biotech sector experienced a remarkable surge in 2025, with small biotech companies emerging as key drivers of innovation. The NASDAQ Biotechnology Index showcased the sector's strength, climbing from 3,637.05 in October 2023 to a peak of 4,954.813 by September 2024, before pulling back to 4,530